HPV Self-Sampling Key for Cancer Screening in Transgender Patients

May 7, 2024

 • 

Read time:

<5 mins
National Institute Of Allergy And Infectious Diseases WCN8lfZX4ZI Unsplash

Researchers at the Michigan School of Public Health have identified a new human papillomavirus (HPV) self-sampling method for cancer screening among transgender and gender diverse (TGD) individuals assigned female at birth (AFAB). Andrew Brouwer, assistant professor of epidemiology and senior author, discusses key findings from his research.

More from the Alumni Education Gateway
Join the Alumni Education Gateway Email List​
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.